Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Aerts

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Genes, Chromosomes & Cancer|April 12, 2024
FGFR1 fusions as a novel molecular driver in rhabdomyosarcomaHenry de Traux De Wardin, Joanna Cyrta, Josephine K Dermawan, et al.
Investigative Ophthalmology & Visual Science|September 23, 2016
Combination of Carboplatin and Bevacizumab Is an Efficient Therapeutic Approach in Retinoblastoma Patient-Derived XenograftsFranck Assayag, André Nicolas, Sophie Vacher, et al.
Pediatric Blood & Cancer|January 31, 2012
Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: toxicity and efficacy trendsMarie-Laure Couec, Nicolas André, Estelle Thebaud, et al.
Pediatric Blood & Cancer|March 29, 2019
SFCE METRO-01 four-drug metronomic regimen phase II trial for pediatric extracranial tumorMarie-Amélie Heng-Maillard, Arnauld Verschuur, Audrey Aschero, et al.
Ophthalmology|January 29, 2008
Conservative treatments of intraocular retinoblastomaLivia Lumbroso-Le Rouic, Isabelle Aerts, Christine Lévy-Gabriel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2022
Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600-Mutant Low-Grade GliomaEric Bouffet, Birgit Geoerger, Christopher Moertel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Outcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut CurieIsabelle Aerts, Hélène Pacquement, François Doz, et al.
Neuro-Oncology Practice|December 29, 2025
Dabrafenib in pediatric patients with <i>BRAF</i> V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm studyBirgit Geoerger, Lucas Moreno, Eric Bouffet, et al.
Ocular Oncology and Pathology|October 30, 2023
Diffuse Infiltrating Retinoblastoma with Anterior Chamber Involvement: Conservative Management and Identification of <i>RB1</i> Alterations in Aqueous HumorNathalie Cassoux, Denis Malaise, Livia Lumbroso-Le-Rouic, et al.
Pediatric Blood & Cancer|January 16, 2018
Enrollment in early-phase clinical trials in pediatric oncology: The experience at Institut CurieAurore Surun, Marie-Églantine Dujaric, Isabelle Aerts, et al.
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Genes, Chromosomes & Cancer|April 12, 2024
FGFR1 fusions as a novel molecular driver in rhabdomyosarcomaHenry de Traux De Wardin, Joanna Cyrta, Josephine K Dermawan, et al.
Investigative Ophthalmology & Visual Science|September 23, 2016
Combination of Carboplatin and Bevacizumab Is an Efficient Therapeutic Approach in Retinoblastoma Patient-Derived XenograftsFranck Assayag, André Nicolas, Sophie Vacher, et al.
Pediatric Blood & Cancer|January 31, 2012
Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: toxicity and efficacy trendsMarie-Laure Couec, Nicolas André, Estelle Thebaud, et al.
Pediatric Blood & Cancer|March 29, 2019
SFCE METRO-01 four-drug metronomic regimen phase II trial for pediatric extracranial tumorMarie-Amélie Heng-Maillard, Arnauld Verschuur, Audrey Aschero, et al.
Ophthalmology|January 29, 2008
Conservative treatments of intraocular retinoblastomaLivia Lumbroso-Le Rouic, Isabelle Aerts, Christine Lévy-Gabriel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2022
Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric <i>BRAF</i> V600-Mutant Low-Grade GliomaEric Bouffet, Birgit Geoerger, Christopher Moertel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Outcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut CurieIsabelle Aerts, Hélène Pacquement, François Doz, et al.
Neuro-Oncology Practice|December 29, 2025
Dabrafenib in pediatric patients with <i>BRAF</i> V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm studyBirgit Geoerger, Lucas Moreno, Eric Bouffet, et al.
Ocular Oncology and Pathology|October 30, 2023
Diffuse Infiltrating Retinoblastoma with Anterior Chamber Involvement: Conservative Management and Identification of <i>RB1</i> Alterations in Aqueous HumorNathalie Cassoux, Denis Malaise, Livia Lumbroso-Le-Rouic, et al.
Pediatric Blood & Cancer|January 16, 2018
Enrollment in early-phase clinical trials in pediatric oncology: The experience at Institut CurieAurore Surun, Marie-Églantine Dujaric, Isabelle Aerts, et al.
Pageof 13